Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 7
2005 3
2006 6
2007 7
2008 5
2009 10
2010 15
2011 7
2012 7
2013 11
2014 10
2015 14
2016 10
2017 10
2018 12
2019 7
2020 10
2021 8
2022 9
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention.
Pettersen TR, Schjøtt J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos HD, Larsen AI, Nordrehaug JE, Rasmussen TB, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekvål TM; CONCARD Investigators. Pettersen TR, et al. Heart Lung Circ. 2024 Mar;33(3):350-361. doi: 10.1016/j.hlc.2023.12.005. Epub 2024 Jan 18. Heart Lung Circ. 2024. PMID: 38238118 Free article.
Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in abdominal obesity: a randomized double-blind crossover study.
Laupsa-Borge J, Grytten E, Bohov P, Bjørndal B, Strand E, Skorve J, Nordrehaug JE, Berge RK, Rostrup E, Mellgren G, Dankel SN, Nygård OK. Laupsa-Borge J, et al. Front Nutr. 2023 Jun 19;10:1020678. doi: 10.3389/fnut.2023.1020678. eCollection 2023. Front Nutr. 2023. PMID: 37404855 Free PMC article.
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.
Gyldenkerne C, Maeng M, Kjøller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Erik Bøtker H, Engstrøm T, Matsumura M, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Rosen HC, Stone GW, Erlinge D. Gyldenkerne C, et al. Among authors: nordrehaug je. Circulation. 2023 Feb 7;147(6):469-481. doi: 10.1161/CIRCULATIONAHA.122.061983. Epub 2022 Dec 16. Circulation. 2023. PMID: 36524476
Everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: a randomized controlled trial.
Eriksen E, Neghabat O, Saeed S, Herstad J, Nordrehaug JE, Tuseth V, Holm NR, Holck EN, Sejr-Hansen M, Maule CF, Barkholt TØ, Andreasen LN, Christiansen EH, Bleie Ø. Eriksen E, et al. Coron Artery Dis. 2023 Jan 1;34(1):1-10. doi: 10.1097/MCA.0000000000001202. Epub 2022 Nov 22. Coron Artery Dis. 2023. PMID: 36484214 Clinical Trial.
153 results